[
    [
        {
            "time": "",
            "original_text": "贝达药业：上半年净利润同比增长30.99%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "净利润",
                    "同比增长",
                    "30.99%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：上半年净利润同比增长30.99%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "“抗癌第一股”贝达药业上市3年10高管出走 超98%营收靠单一产品支撑新药研发暂停 董监高成员变化",
            "features": {
                "keywords": [
                    "贝达药业",
                    "抗癌第一股",
                    "高管出走",
                    "98%营收",
                    "单一产品",
                    "新药研发暂停",
                    "董监高成员变化"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“抗癌第一股”贝达药业上市3年10高管出走 超98%营收靠单一产品支撑新药研发暂停 董监高成员变化",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]